Florian Losch


Affiliation: Humboldt University
Country: Germany


  1. request reprint
    Losch F, Holtkamp M, McMurray R, Lendemans D, Kockelmann E. [Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany]. Nervenarzt. 2016;87:1094-1099 pubmed
    ..The overall tolerability of ESL add-on therapy was favorable: 32 adverse events (AE) were reported in 20 patients (19.2?%), while only two events in two patients were considered serious. No new safety signals were detected. ..

Detail Information